NASDAQ:TMDX TransMedics Group Q3 2026 Earnings Date & Estimates $70.74 -1.32 (-1.83%) Closing price 10/23/2026 04:00 PM EasternExtended Trading$69.94 -0.80 (-1.13%) As of 10/23/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. TransMedics Group is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 5, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from TransMedics Group in Q3 2026TransMedics Group is expected to post earnings of $0.2976 per share on revenue of $178.06 million. In the same quarter a year earlier TransMedics Group reported $0.66 per share on revenue of $143.82 million. TransMedics Group last reported on August 4, 2026, posting $0.44 per share and missing the $0.4955 consensus estimate. TransMedics Group has beaten the consensus EPS estimate in 5 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.2976Expected Revenue$178.06 millionPrior-Year EPS$0.66Prior-Year Revenue$143.82 millionExpected EPS Growth-54.9%Expected Revenue Growth+23.8%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.44 (Missed by -$0.0555)Last Quarter Revenue$189.95 millionEPS Beat Rate5 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ3 2025 Earnings Report TransMedics Group Q3 2026 Earnings FAQ When does TransMedics Group report Q3 2026 earnings? TransMedics Group (NASDAQ:TMDX) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is TransMedics Group's Q3 2026 earnings call? TransMedics Group's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for TransMedics Group? Analysts expect TransMedics Group to post earnings of $0.2976 per share for Q3 2026. How much revenue is TransMedics Group expected to report? The consensus revenue estimate for TransMedics Group is $178.06 million for Q3 2026. TransMedics Group Earnings HeadlinesTransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026October 22 at 4:05 PM | prnewswire.comTransMedics Group (NASDAQ:TMDX) & QuidelOrtho (NASDAQ:QDEL) Financial ComparisonOctober 22 at 2:15 AM | americanbankingnews.com“The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 yearsDr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehman Brothers, is warning of a developing financial crisis. The New York Times has credited him as among the first to see the dangers ahead, and Forbes dubbed him Mr. Independence. He says this emerging situation could trigger a chain reaction across banks and markets. Watch his free video breakdown and see the five steps he outlines for investors.October 24 at 1:00 AM | Weiss Ratings (Ad)TransMedics Group Inc TMDXOctober 20, 2026 | morningstar.comMTransMedics Group - Some Hiccups In The Long Term Growth StoryOctober 20, 2026 | seekingalpha.comTransMedics Group (TMDX) Stock Looks Undervalued On Current EarningsOctober 17, 2026 | finance.yahoo.comSee More TransMedics Group Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like TransMedics Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TransMedics Group and other key companies, straight to your email. Email Address About TransMedics GroupTransMedics Group (NASDAQ:TMDX) is a medical technology company focused on improving organ transplantation through systems that preserve and assess donor organs outside the body. The company’s primary platform is the Organ Care System (OCS), a portable, technology-enabled perfusion system designed to maintain organs in a functioning, near-physiologic state during transport and evaluation. TransMedics offers OCS products for heart, lung and liver transplantation. Its systems are intended to support the use of organs that may not otherwise be suitable for conventional cold-storage methods, potentially expanding the donor pool and providing transplant teams with additional information when evaluating organs for transplantation. Founded in 1998 and headquartered in Andover, Massachusetts, TransMedics serves transplant centers in the United States and select international markets. The company also operates the National OCS Program, which combines its organ-preservation technology with logistical and clinical services to help coordinate organ retrieval, transportation and transplantation. Waleed Hassanein is TransMedics’ president and chief executive officer.View TransMedics Group ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/19 - 10/23Amex Stock Slides on Job Cuts, But the Real Story Is MacroBloom Energy Just Reported—Its Biggest Order Is Still Waiting on a PipelineLockheed Martin’s Record $292 Billion Backlog Comes With a Delivery TestSpotify Soars After Earnings as the Company Touts AI Benefits and Moderating CostsWhy Western Digital's AI Storage Boom Defies the Chip Sell-OffPalantir's Next Big Test Isn't a Partnership—It's the Numbers Upcoming Earnings Verizon Communications (10/26/2026)Nucor (10/26/2026)Public Storage (10/26/2026)Welltower (10/26/2026)Cadence Design Systems (10/26/2026)Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Coca Cola Femsa (10/27/2026)Baker Hughes (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
